Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rebecca Nagy

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancerHuiling He, Wei Li, Sandya Liyanarachchi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Risk Factors of <sup>131</sup>I-Induced Salivary Gland Damage in Thyroid Cancer PatientsBrynn Hollingsworth, Leigha Senter, Xiaoli Zhang, et al.
JCO Precision Oncology|February 1, 2022
Circulating Tumor DNA Profiling of Advanced Biliary Tract CancersKabir Mody, Pashtoon M Kasi, JuDong Yang, et al.
Endocrine-Related Cancer|September 9, 2010
Role of PTPRJ genotype in papillary thyroid carcinoma riskRodolfo Iuliano, Dario Palmieri, Huiling He, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2013
Cumulative risk impact of five genetic variants associated with papillary thyroid carcinomaSandya Liyanarachchi, Anna Wojcicka, Wei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
British Journal of Cancer|January 20, 2022
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinomaKyrillus S Shohdy, Dario M Villamar, Yen Cao, et al.
Cancer Discovery|March 10, 2017
An Acquired <i>HER2</i><sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast CancerAriella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Science (New York, N.Y.)|April 9, 2011
Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD IHuiling He, Sandya Liyanarachchi, Keiko Akagi, et al.
Plos One|May 22, 2013
Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetranceHuiling He, Wei Li, Dayong Wu, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Proceedings of the National Academy of Sciences of the United States of America|April 29, 2015
Multiple functional variants in long-range enhancer elements contribute to the risk of SNP rs965513 in thyroid cancerHuiling He, Wei Li, Sandya Liyanarachchi, et al.
The Journal of Clinical Endocrinology and Metabolism|August 18, 2016
Risk Factors of <sup>131</sup>I-Induced Salivary Gland Damage in Thyroid Cancer PatientsBrynn Hollingsworth, Leigha Senter, Xiaoli Zhang, et al.
JCO Precision Oncology|February 1, 2022
Circulating Tumor DNA Profiling of Advanced Biliary Tract CancersKabir Mody, Pashtoon M Kasi, JuDong Yang, et al.
Endocrine-Related Cancer|September 9, 2010
Role of PTPRJ genotype in papillary thyroid carcinoma riskRodolfo Iuliano, Dario Palmieri, Huiling He, et al.
Thyroid : Official Journal of the American Thyroid Association|May 11, 2013
Cumulative risk impact of five genetic variants associated with papillary thyroid carcinomaSandya Liyanarachchi, Anna Wojcicka, Wei Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2017
<i>PIK3CA</i> C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3K<b>α</b> InhibitorsSarah Croessmann, Jonathan H Sheehan, Kyung-Min Lee, et al.
British Journal of Cancer|January 20, 2022
Serial ctDNA analysis predicts clinical progression in patients with advanced urothelial carcinomaKyrillus S Shohdy, Dario M Villamar, Yen Cao, et al.
Cancer Discovery|March 10, 2017
An Acquired <i>HER2</i><sup>T798I</sup> Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast CancerAriella B Hanker, Monica Red Brewer, Jonathan H Sheehan, et al.
Science (New York, N.Y.)|April 9, 2011
Mutations in U4atac snRNA, a component of the minor spliceosome, in the developmental disorder MOPD IHuiling He, Sandya Liyanarachchi, Keiko Akagi, et al.
Plos One|May 22, 2013
Ultra-rare mutation in long-range enhancer predisposes to thyroid carcinoma with high penetranceHuiling He, Wei Li, Dayong Wu, et al.
Pageof 5